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Abstract
Background: Schistosomiasis affects the reproductive health of women. Described sequelae are
ectopic pregnancy, infertility, abortion, and cervical lesions and symptoms mimicking cervical
cancer and STIs. There are indications that cervical schistosomiasis lesions could become co-
factors for viral infection such as HIV and HPV.
Methods: In a retrospective descriptive histopathological study clinical specimens sent between
1999 and 2005 to the pathology department of a consultant hospital in Tanzania were reviewed to
analyse the occurrence and features of schistosomiasis in female genital organs.
Results:  During the study period, schistosomiasis was histopathologically diagnosed in 423
specimens from different organs (0.7% of all specimens examined in the study period), out of those
40% were specimens from female and male organs. The specimens were sent from 24 hospitals in
13 regions of mainland Tanzania. Female genital schistosomiasis was diagnosed in 125 specimens
from 111 patients. The main symptoms reported were bleeding disorders (48%), ulcer (17%),
tumor (20%), lower abdominal pain (11%) and infertility (7%). The majority of cases with genital
schistosomiasis were diagnosed in cervical tissue (71 cases). The confirmation of cervical cancer
was specifically requested for 53 women, but the diagnosis could only be verified for 13 patients
(25%), in 40 cases only severe cervical schistosomiasis was diagnosed. Vulval/labial schistosomiasis
was seen in specimens from young women. Infertility was reported in four patients with
schistosomiasis of the Fallopian tubes.
Conclusion: Genital schistosomiasis adds to the disease burden of women in all age groups.
Pathological consequences due to the involvement of different genital organs can be damaging for
the affected women. Clinical unawareness of genital schistosomiasis can lead to misdiagnosis and
therefore false and ineffective therapy. In endemic areas cervical schistosomiasis should be
considered as differential diagnosis of cancer.
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Background
Ill-health due to reproductive health problems and sexu-
ally transmitted infections (STIs) is mostly both preventa-
ble and remediable to its nature. These illnesses,
notwithstanding, account for almost one fifth of the
health burden in women [1]. Many go unrecognised,
since, as could be expected, the heaviest toll befalls
women in the poorest countries where services are lim-
ited. Sexual and reproductive health are affected by socio-
cultural factors; both at individual and societal level stig-
matization and shame are deeply engrained factors influ-
encing whatever actions are taken against these diseases
and their symptoms.
Although both health professionals and the public are
aware of the dismal statistics for STIs, few seem to realize
that there are other infectious agents than bacteria and
virus that can havoc and complicate reproductive health.
Symptoms and signs associated with a STI are not uncom-
mon in schistosomiasis, a parasitic helminth disease
afflicting around 250 million people, again in the poorest
countries where services are limited [2]. More than is usu-
ally acknowledged schistosomiasis affects the reproduc-
tive organs of women. Female genital schistosomiasis was
described for the first time in a young Egyptian woman
more than 100 years ago [3], but still awaits its proper
place among the public health explanatory and target fac-
tors for sexual and reproductive ill-health. Schistosomia-
sis and its association with ectopic pregnancy, infertility,
abortion, and cervical lesions similar to STI or cervical
cancer have been described in many case reports [4]. Cer-
vical schistosomiasis causes damages of the epithelium
and these lesions, if manifest before sexual debut, could
become considerable co-factors for the transmission of
viral infections such as HIV and HPV infections in early
ages [5,6].
Systematic histopathology studies made by pathologists
and gynecologists in schistosomiasis endemic areas in the
1970s and 1980s have confirmed the presence of schisto-
soma eggs and adult worms in upper and lower female
genital organs [7-12]. The relation of schistosomiasis to
cervical cancer has only rarely received attention [13,14].
Cervical cancer is the most common malignancy among
women in African countries [15]. Since diagnosis and
treatment are inadequate or non-existent even in tertiary
hospitals, women often present at a hospital in an
advanced and desolate stage of the disease [16,17].
Tanzania belongs to the poorest countries in the world
[18]. Its health care has to struggle with an overwhelming
burden of diseases relying on a weak infrastructure. Infec-
tious diseases are prominent, notably so sexually trans-
mitted ones. STIs, including HIV, have already been seen
in primary school-children, although at a low level [19].
At least one ongoing treatable reproductive tract infection
was present in 64 percent of women attending urban pri-
mary healthcare facilities in the Northern Region and in
39 percent of women attending antenatal care in rural
health care facilities [20,21]. Professional knowledge and
awareness of female genital schistosomiasis can bring a
lot to the quality of care in sexual and reproductive health.
In this article we present evidence of female genital schis-
tosomiasis in referred specimens to a pathology depart-
ment in Northern Tanzania.
Methods
The Kilimanjaro Christian Medical Centre (KCMC) is the
consultant hospital for over 12 to 15 million inhabitants
of Northern Tanzania. It is also the Medical College of the
Tumaini University. The Department of Pathology
receives biopsies and surgical specimens from over 50
hospitals all over the country, which means that they are
responsible for about 35 percent of this type of examina-
tions made in Tanzania. Around 5,000 specmines of all
kinds are processed yearly.
The specimens are routinely fixed and preserved in 10 per-
cent formaldehyde for transportation. At KCMC the tis-
sues were paraffin-embedded. Five to 7 μm thick sections
are cut on a microtome and mounted onto microscope
slides. The sections are stained with Hematoxylin and
Eosin for the microscopical examination. Two slides are
prepared and analysed from each paraffin-embedded
block.
All surgical specimens sent to or taken at KCMC between
1994 and 2005 in which the histopathological diagnosis
of schistosomiasis was established were reviewed. Age,
provisional diagnosis and symptoms, when available, as
well as all specific histopathology information were noted
for the female patients where the examination had shown
the presence of schistosomiasis.
Ethical considerations
This study is part of a larger project "Sustainable Preven-
tion of Endemic Schistosomiasis" (SPES), a research col-
laboration between KCMC and the Skaraborg Institute for
Research and Development, Skövde, Sweden. Ethical
clearance was given by the Research and Ethical Commit-
tee of the KCMC, Tumaini University, Tanzania. Research
data were processed and stored anonymously.
Results
During the study period (12 years) 423 organ specimens
examined at Department of Pathology (equals 0.7% of
the total number of specimens during this time period)
had a histopathologically confirmed schistosomiasis diag-
nosis. In 172 cases (40.7%) schistosomiasis was diag-BMC Infectious Diseases 2006, 6:134 http://www.biomedcentral.com/1471-2334/6/134
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nosed in bladder and/or urethra and/or urether
specimens, in 15 cases (3.5%) in liver specimens, in 45
cases (10.6%) in intestine specimens (jejunum, colon,
appendix, rectum) and in 8 cases (1.9%) in mesentery/
omentum. Genital schistosomiasis was diagnosed in 176
specimens from genital organs (41.6%: 115 organ speci-
mens from female patients). Totally, genital specimens
from 111 women were examined. The age of the patients
ranged from five to 61 years, with a median age of 34
years. The specimens were sent from 24 hospitals in 13
regions of mainland Tanzania. Organs represented were
peritoneum, uterus, cervix, ovary, Fallopian tubes, vagina/
vulva, perineum and labia. The specimens consisted of
biopsies from in situ and removed organs. The provi-
sional diagnosis on the referral form was mostly a suspi-
cion of malignancy. The main symptoms reported were
bleeding disorders (48%), ulcer (17%), tumor (20%),
lower abdominal pain (11%), and infertility (7%).
Eleven percent of the specimens came from women less
than 20 years old. Table 1 shows the age distribution per
organ examined. In 84 patients (75%) no other diagnosis
besides schistosomiasis was established.
Schistosomiasis was seen in simultaneously in two sites in
13 patients and in three sites in two patients with the fol-
lowing combinations, cervix and uterus; uterus and peri-
toneum; ovary and Fallopian tube; ovary and peritoneum;
uterus, cervix and ovary. In five specimens schistosome
eggs as well as adults worms were detected (labia, cervix,
and ovary).
Specimens from the cervix only or in combination with 
other organs
Of all the 71 cervical specimens 14 (20%) showed signs of
malignancy; epithelial dysplasia (4), carcinoma in situ
(2), squamous cell carcinoma (6), adenocarcinoma (1)
and lymphangiosis carcinoma (1). In the rest schistosto-
somias associated with chronic inflammation was diag-
nosed.
For the 62 patients in this group symptoms reported were
intermenstrual bleeding, post-coital bleeding, irregular
menstruation, contact bleeding, and post-menopausal
bleeding, with a median duration of symptoms given as
four months (range 2 – 96 months). The clinical findings
were described in 31 patients as suspicious appearance of
the cervix (61%), ulcer/erosion (35%), growth/polyp
(16%), tumor (13%), and friable/hard/nodular cervix
(13%).
The median age of the women with or without cervical
malignancy was 39 years.
The verification of a provisional carcinoma diagnosis was
explicitly requested for 53 patients (Table 2). The carci-
noma diagnosis could be confirmed for 13 of them.
Specimens from uterus/endometrium
Three of the ten uterine specimens showed only severe
schistosomiasis. Schistosomiasis was associated with leio-
myoma in four specimens, and in one specimen each with
adenomyosis, adenomyosis/leiomyoma, and endometri-
tis. Seven patients had undergone total hysterectomia, in
one case with right salpingo-oophorectomia. One patient
(28 years) had a hysterectomia performed due to a tumor
of the cervix, however, the histopathology diagnosis of
this case was severe schistosomiasis of the cervix and
uterus. In one patient a squamous epithelial carcinoma
associated with schistosomias was diagnosed in the blad-
der, the right and left ureter, and the uterus. In seven spec-
imens of the endometrium, schistosomiasis was
diagnosed; in one of these cases concomitant tuberculosis
could not be ruled out.
Fallopian tubes/ovary/peritoneum
This group consisted of 14 samples from ovarian tissue
and five from the Fallopian tubes. Severe scarring due to
schistosomiasis was seen in one case and in two cases
there was a specific inflammatory reaction. In three cases
schistosomiasis of the peritoneum, in one schistosomiasis
of pelvic tissue, and in one schistosomiasis of a lymphn-
ode was also noted. Infertility was reported in four
patients where tubal schistosomiasis was found (21, 25,
31 and 33 years old). A provisional diagnosis of cancer
was confirmed in two out of seven women (Table 2).
Labia/vulva/perineum
Schistosomiasis of the external genital organs was only
seen in girls and one young woman: vulva (1 case: 8 years
old), perineum (2 cases: 5 and 6 years old) and labia (5
cases: 10, 11, 13, 13 and 18 years old). Labial tumors were
Table 1: Number of examined organs per age group of 105 of the 
111 female patients for whom age information was available. 
Percentages in brackets.
Specimena Agegroup (years)
5 – 19 20 – 29 30 – 39 ≥ 40
Cervix 2 (20) 15 (47) 18 (50) 28 (74)
Uterus 1 (10) 5 (16) 5 (14) 7 (18)
Ovary 5 (16) 7 (19) 2 (5)




Peritoneum 4 (13) 4 (11)
Total 10 32 36 38
a double registration possible.
b age range: 8 – 18 years.BMC Infectious Diseases 2006, 6:134 http://www.biomedcentral.com/1471-2334/6/134
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reported in the request form in four cases, in two cases
associated with ulcera and verrucous skin.
Discussion
Schistosomiasis is an important and highly prevalent
helminthic infection related to water contact and poverty
and is affecting approximately 250 million people living
in the tropical and sub-tropical parts of Sub-Saharan
Africa, Asia and South America [2]. The number of
women with schistosomiasis-related signs and symptoms
thus ought to be high and could easily concern millions.
Re-assessing the world-wide clinical morbidity caused by
schistosomes, however, van der Werf et al. [22] have not
included the clinical picture of genital schistosomiasis in
the analysis because of insufficient data. Since the first
description more than 100 years ago, numerous case
reports published over decades in journals of different
specialities (gynaecology, pathology, urology, histology,
tropical medicine) have presented clinical features – often
described as unusual – of genital schistosomiasis in
female patients. In 1949 Charlewood concluded by exam-
ining reports of the South African Institute of Medical
Research: "...it is apparent that practically all gynaecolo-
gists who have been practising in Johannesburg and Dur-
ban for any length of time have encountered
gynaecological manifestations of Bilharzia. Yet, it is sur-
prising how meagre and unsatisfactory is the literature on
the subject" [23]. The situation has not changed. System-
atic research on the morbidity caused by genital involve-
ment during the course of a schistosome infection is so far
sketchy and research on the possible impact of genital
schistosomiasis on viral co-infections is to our mind virtu-
ally non-existent.
Retrospective histopathology studies carried out in Egypt,
Malawi, Mozambique, South Africa, Tanzania and Zimba-
bwe have shown that genital involvement mainly caused
by Schistosoma haematobium most often occur in the
vagina and cervix, less frequently in the ovary, tube and
uterus. Gelfand et al. [24] found in a series of consecutive
autopsies, using the sensitive digestion method, schisto-
some eggs in female genital organs in 58 percent of the
cases. Investigations based on specimens from gynaeco-
logical surgical interventions (biopsies, curettage, organ
exstirpation) can give information about the relative fre-
quency of pathological changes in the different genital
organs. In Gabon, Mozambique, Malawi and Madagaskar
female genital schistosomiasis has been diagnosed in
from 0.7 percent (Madagascar) up to 29 percent (Mozam-
bique) of such genital specimens [11,12,25,26]. In cases
of ectopic pregnancy, tubal schistosomiasis was found in
Cote d'Ivoire and Gabon in 3.6 and 1.8 percent, respec-
tively [25,27]. On Pemba Island in Tanzania tubal schis-
tosomiasis was diagnosed in 39.8 percent of all cases with
primary or secondary infertility [28]. In Cote d'Ivoire
schistosomiasis of the placenta was diagnosed in a pro-
spective study in 22.3 percent of 322 cases. When a sub-
group of 87 of patients were examined for urinary schisto-
somiasis, in only 12.6 percent of the women the diagnosis
of urinary schistosomiasis could be confirmed [8].
Out of the 423 cases with a histopathological confirmed
diagnosis of schistosomiasis the genital and urinary
involvement occurred to the same degree (41% and 42%).
In no case a provisional diagnosis of female genital schis-
tosomiasis was mentioned on the request forms. Whereas
six percent of the cases were due to multi-focal infections
in Malawi [11], we found involvement in more than one
organ in 12 percent.
Genital schistosomiasis is associated with bleeding disor-
ders, lower abdominal pain but also with infertility. A
simultaneous affection of the ovaries and Fallopian tubes
and/or peritoneum, as was found in our material, has
been reported previously [29-31]. A high tissue egg bur-
den is associated with generalized inflammation and
Table 2: Results of the histopathology examination for patients with the provisional diagnosis of carcinoma on the request form.
Specimen Provisional diagnosis – carcinoma Histological diagnosis
Carcinoma and schistosomiasis Schistosomiasis only
Cervix
Only cervix 47 12 35
Cervix and uterus 4 4
Cervix and endometrium 1 1
Cervix and vagina 1 1
Ovary
Only ovary 4 2 2
Ovary and uterus 1 1
Ovary and Fallopian tubes 1 1
Ovary and peritoneum 1 1BMC Infectious Diseases 2006, 6:134 http://www.biomedcentral.com/1471-2334/6/134
Page 5 of 8
(page number not for citation purposes)
fibrosis and thus mechanically impairs the tubal motility
or the tubal patency [32-34]. Ectopic pregancies or infer-
tility are the highly possible outcomes of this [28,35-38].
Cervical schistosomiasis as a chronic disease persisting for
years causes damages of the cervical epithelium and can
theoretically render the local immune environment
favourable for viral infections such as caused by HIV and
human papilloma virus (HPV) [5,6]. Impaired cell-medi-
ated immunity has been shown in patients with schisto-
somiasis of the urinary bladder associated with carcinoma
of the bladder or of the prostate [39]. Clinical evidence
corroborates this hypothesis. Firstly, according to cross-
sectional studies carried out in schistosomiasis-endemic
areas cervical involvement is common. Secondly, analys-
ing prevalence data so far available, one can see a correla-
tion between prevalence of urinary schistosomiasis and
cervical schistosomiasis; the higher the prevalence of uri-
nary schistosomiasis the higher the prevalence of cervical
schistosomiasis (Figure 1). Thirdly, cervical schistosomia-
sis is associated with lesions such as sandy patches, ero-
sion, mucosal bleeding, and abnormal blood vessels
[40,41]. The clinical features seen in the patients of our
study were cervical tumors, friable, easily bleeding cervix,
and suspect appearance of the cervix. Berry [42] in an
extensive series of histopathological investigations of cer-
vical specimens, noted presence of eggs without inflam-
mation; mild cervicitis with scattered lymphocytes,
histiocytes and plasma cells, sometimes associated with
atrophic epithelium; scattered eosinophils throughout the
connective tissue; interstitial hemorrhage, chronic cervici-
tis often with ulceration. Lesions in the cervix impair the
epithelial integrity and thus make it biologically plausible
that schistosomiasis can increase the risk for transmission
of HIV-infection in the same way as is seen in other genital
ulcer disease [43]. This could of course be valid for other
infectious agents with the same transmission pattern as
HIV. Another memento is that the mucosal changes by
schistosomiasis could already be there before the young
women starts their sexual-reproductive life.
The possible association between cervical cancer and cer-
vical schistosomiasis have been studied retrospectively by
histopathology analysis. Genital schistosomiasis was
diagnosed in 1.7, 1.9 and 3.0 percent of cases with cervical
cancer in three studies from Malawi and Tanzania
[11,13,14]. In all the studies the percentage of cervical
schistosomiasis detected in cervical tissue without cervical
cancer was higher (4.3%, 6.0%, 9.8%). A possible expla-
nation for these findings is the fact that the clinical fea-
tures of cervical schistosomiasis simulate those produced
by malignancy. The results of our study point in this direc-
tion: the provisional diagnosis of cervical cancer in
patients with genital schistosomiasis could be confirmed
in only 20 percent of the patients. As a consequence
women might undergo surgery such as hysterectomy on
false clinical premises, which we saw in our study. The
studies carried out so far cannot support the hypothesis of
cervical schistosomiasis being a co-factor to HPV infection
for the development of cancer. It has, however, been
brought forward that chronic cervical inflammation and
parasitic infection impairing the cellular immunity might
contribute to the high prevalence of HPV types other than
HPV16 seen in sub-Saharan Africa [44]. Petry et al. [45]
showed that the HPV prevalence of patients orignating
from endemic areas in Tanzania and from German con-
trols were similar (34.5% versus 26.9%), however,
women with a history suggestive for schistosomiasis and/
or active schistosomiasis had a higher risk for habouring
high risk HPV types. The authors concluded that the infec-
tion with S. haematobium sems to favor persistent genital
HPV infection either by traumatizing the general epithe-
lium and/or by local immunosuppression. Additionally,
the interplay of HIV, schistosomiasis and HPV might very
well have an impact on HPV infection. Reporting two
cases of HIV-positive women with schistosomiasis of the
cervix Prabhakaran and Brown [46] proposed timely treat-
ment against schistosomiasis to prevent aggressive HPV
infection and its consequences in HIV-infected patients.
The authors argue that persistent schistosomiasis may
result in earlier HPV relapses because schistosomiasis
increases the likelikhood of STDs. Recently, two cases of
cervical schistosomiasis and squamous cell carcinoma
have been reported in which high-risk HPV could not be
detected [47], however, with the low number of speci-
mens the possibilty of false negative test results and/or
insuffienct conservation have to be considered as alterna-
tive explanation [48]. Another possible patho-mechanism
might be the inactivation of tumor suppressor genes.
Mutations of the p53 tumor suppressor gene which
encodes a protein involved in the growth and regulation
of cells and of components of the DNA damage control
response is one of the most frequent genetic alteration in
a variety of malignancies. Mutations in the tumor sup-
pressor gene p53 have been observed more frequently in
patients with schistosomiasis-associated bladder cancer
compared to patients with non-schistosomiasis associated
bladder cancer [49].
Conclusion
The retrospective histopathological data presented give an
overview of the occurrence of schistosomiasis in genital
organs in women living in a schistosomiasis endemic
area. Conclusions on the prevalence of female genital
schistosomiasis in the different genital organs can not be
drawn from this type of study. However, the results indi-
cate that genital schistosomiasis has to be considered as
differential diagnosis in a schistosomiasis endemic areas.
Genital schistosomiasis misdiagnosed as cancer can be
detrimental and devastating, if surgery is done. Further-BMC Infectious Diseases 2006, 6:134 http://www.biomedcentral.com/1471-2334/6/134
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more, cervical genital schistosomiasis misdiagnosed as an
STI can lead to ineffective treatment. Schistosome-, HIV-
and HPV-infections are highly prevalent in sub-Saharan
Africa, indications that cervical schistosomiasis can influ-
ence the course of STIs are at hand.
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Combined analysis of data from five schistosomiasis-endemic countries Figure 1
Combined analysis of data from five schistosomiasis-endemic countries. Relation between prevalence of urinary schistosomia-
sis and the occurrence of genital schistosomiasis of the cervix uteri in women with urinary schistosomiasis.
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Blue dots: Tanzania, community-based studies, diagnosis by biopsy (five villages, total n = 460)
(unpublished data) [40]
Red dot: Madagascar, community-based study, diagnosis in sub-group of study participants by biopsy (n 
= 36) [50]
Green dot: Niger, community-based study, diagnosis by biopsy (n = 61) [51]
Pink dot: Malawi, hospital-based study, diagnosis by biopsy, only women with urinary schistosomiasis
included (n = 51) [52]
Yellow dot: Zimbabwe, community-based study, diagnosis on clinical grounds (n = 527) [41]BMC Infectious Diseases 2006, 6:134 http://www.biomedcentral.com/1471-2334/6/134
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